2 Matching Annotations
  1. Mar 2021
  2. bhekisisa.org bhekisisa.org
    Why South Africa isn’t using the AstraZeneca jabs it bought – Bhekisisa
    1
    1. forbriger 31 Mar 2021

      Team, B. (2021, March 29). Why South Africa isn’t using the AstraZeneca jabs it bought. Bhekisisa. https://bhekisisa.org/health-news-south-africa/2021-03-29-why-south-africa-isnt-using-the-astrazeneca-jabs-it-bought/

      is:news lang:en COVID-19 vaccine South Africa AstraZeneca Serum Institute of India 501Y.V2 variant effective WHO government
    Visit annotations in context

    Tags

    Annotators

    URL

    bhekisisa.org/health-news-south-africa/2021-03-29-why-south-africa-isnt-using-the-astrazeneca-jabs-it-bought/
  3. Feb 2021
  4. www.biorxiv.org www.biorxiv.org
    http://biorxiv.org/cgi/content/short/2021.01.18.427166
    1
    1. marta_radosevic 18 Feb 2021

      Wibmer, C. K., Ayres, F., Hermanus, T., Madzivhandila, M., Kgagudi, P., Lambson, B. E., Vermeulen, M., Berg, K. van den, Rossouw, T., Boswell, M., Ueckermann, V., Meiring, S., Gottberg, A. von, Cohen, C., Morris, L., Bhiman, J. N., & Moore, P. L. (2021). SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. BioRxiv, 2021.01.18.427166. https://doi.org/10.1101/2021.01.18.427166

      is:preprint lang:en COVID-19 South Africa SARS-CoV-2 501Y.V2 mutation reinfection efficacy vaccine research transmission strain
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2021.01.18.427166v1